Home/Filings/4/0001415889-20-001939
4//SEC Filing

Pennington James 4

Accession 0001415889-20-001939

CIK 0001604191other

Filed

Jul 19, 8:00 PM ET

Accepted

Jul 20, 9:54 PM ET

Size

5.5 KB

Accession

0001415889-20-001939

Insider Transaction Report

Form 4
Period: 2020-07-16
Pennington James
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock option (right to buy)

    2020-07-16+300,000300,000 total
    Exercise: $0.85Exp: 2030-07-15Common stock, par value $0.0001 per share (300,000 underlying)
Footnotes (1)
  • [F1]The stock option vests in 36 equal monthly installments over a term of three (3) years beginning on August 16, 2020, conditioned on Mr. Pennington's continued employment by AzurRx BioPharma, Inc. on the applicable vesting date.

Issuer

AzurRx BioPharma, Inc.

CIK 0001604191

Entity typeother

Related Parties

1
  • filerCIK 0001668704

Filing Metadata

Form type
4
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 9:54 PM ET
Size
5.5 KB